WHO brings countries together to test collective pandemic response In a significant step toward improving global pandemic preparedness, the World Health Organization (WHO) recently led a groundbreaking two-day international simulation…
FDA Issues Complete Response Letter to Aldeyra for Reproxalap Dry Eye NDA Aldeyra Therapeutics, Inc.a biotechnology company committed to the development of innovative therapies targeting immune-mediated and metabolic diseases, announced…
Akamis Bio Doses First Patient in Phase 1b Rectal Cancer Trial of NG-350A Akamis Bio, a clinical-stage biotechnology company at the forefront of immuno-oncology innovation, announced a major milestone in…
Xaira Therapeutics Appoints Bo Wang as SVP and Head of Biomedical AI In a strategic move that underscores its deepening commitment to revolutionizing drug discovery through artificial intelligence, Xaira Therapeutics…
GoodRx Introduces New E-commerce Experience for Retail Pharmacies GoodRx, a recognized leader in medication savings platforms across the United States, has announced the introduction of a transformative e-commerce experience designed…
The HRT Club and MyMenopauseRX Team Up to Expand Menopausal Care Access Across 21 States In a major step toward improving access to affordable and patient-centered menopause healthcare, The HRT…
eClinical Solutions Highlights 2025 Shift to Risk-Based Strategies and AI in Clinical Trials eClinical Solutions LLC, a global leader in digital clinical software and services, has released the findings of…
Tecan Enhances Specialty Diagnostics Portfolio With ELISA Kit Asset Acquisition Tecan Group (SIX Swiss Exchange: TECN) has announced a strategic agreement to acquire key ELISA immunoassay assets from Cisbio Bioassays…
Sangamo Licenses Capsid Tech to Lilly for CNS Genomic Medicines Sangamo Therapeutics, Inc., a leader in genomic medicine, has entered into a new licensing agreement with Eli Lilly and Company…
Perth Biosciences Collaborates with Japan’s Scrum Corporation for Distribution Perth Biosciences, a pioneering leader in the accessibility and scalability of single-cell sequencing, has officially announced a strategic agreement with Tokyo-based…
Revvity, Inc. (NYSE: RVTY) has announced that the U.S. Food and Drug Administration (FDA) has granted approval for the Auto-Pure 2400 liquid handling platform in combination with the T-SPOT.TB test.…
Endeavor BioMedicines Welcomes ILD Expert Dr. Lisa Lancaster as Chief Medical Officer Endeavor BioMedicines, a clinical-stage biotechnology company dedicated to developing groundbreaking treatments for life-threatening diseases, has announced the appointment…